New Market Developments in Post-Genome Business 2002

Japanese only

New Market Developments in Post-Genome Business 2002
Interviews primarily with genome-related companies were conducted regarding human genome technology and market development in order to analyze activities in medicine and pharmaceuticals.

New Market Developments in Post-Genome Business 2002

Format: A4 size, 455 pages

On sale: Published in September 2002
Price: JPY95,500
(per copy including delivery charges)

Language used in book: English

Tel. +81-3-5226-0736 Fax. +81-3-5226-0741

Related publications

Order Form

-New Market Developments in Post-Genome Business!-

A bio boom is welling up with the support of genome data analysis, and endeavors are underway to foster it as a 21st Century new industry and Japan's post-genome business as a national project. Private sector companies too are accelerating further their genome drug development, regenerative medicine, and gene therapy based on technologies such as protein structure and functional analysis, and gene functional analysis, and targeting establishment of technologies and businesses before elsewhere in the world.

Detailed analysis based on survey of 25 drug development companies, 22 development support companies, and 45 bio ventures

Innovative 21st Century drugs will be comprised of genome drug development!

-	Relationship between post-genome technology elucidation and drug development.
-	Will antibody medicine become the genome medicine favorite?
-	Alliances of drug development companies and bio ventures and new relationships.
-	Will genome drug development itself mark the opening stage of tailor-made medical treatment?

Probing the possibility of realizing regenerative medicine!

-	Status of regenerative medicine in skin, blood vessel, blood, bone, and nerve sectors.
-	Stem cells or embryonic stem cells?

Developments at companies that support genome drug development and new medical treatment!

-	Bioinformatics and drug development.
-	Development trends in tests, testing equipment, and diagnostic drugs

Bio venture boom and associated trends!

-	Establishment processes and business scope of major venture companies.
-	Movements of drug development venture companies based on Revised Pharmaceuticals Affairs Law and approval of venture companies emerging from universities.
-	Forecast of listing of bio ventures and venture company capital trends.

  Genome structure/functional analysis (DNAERNA, SNP analysis)
   Protein analysis (protein structure analysis, protein function analysis)
   Genome drug development (antibody medicine)
   Regenerative medicine (cell medical treatment)
   Gene medical treatment

1. Bio policy and bio industry political strategy.

2. Bio policy and bio industry political strategy.

3. egenerative medicine development trends.

4. Genome drug development support company development trends

5. Development trends at bio ventures.

6. Future trends and problem issues in genome drug development, antibody medicine, cell medical treatment, and regenerative medicine.